CIT-话题@MedSci

#CIT#

176篇内容 | 3619人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1738519, encodeId=24e61e38519df, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=J Rheumatol ：Baricitinib在类风湿关节炎128周开放标签研究中的安全性和疗效, objectType=article, longId=110969, objectId=71cc1109691e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71cc1109691e, replyNumber=0, likeNumber=62, createdTime=2017-11-25, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71cc1109691e, moduleTitle=J Rheumatol ：Baricitinib在类风湿关节炎128周开放标签研究中的安全性和疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71cc1109691e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738522, encodeId=d6e61e38522bc, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=J Med Econ：草花粉皮下免疫疗法（SCIT）与舌下免疫治疗（SLIT）和对症治疗的成本效益比较分析, objectType=article, longId=125348, objectId=ba4212534824, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba4212534824, replyNumber=0, likeNumber=122, createdTime=2018-10-01, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba4212534824, moduleTitle=J Med Econ：草花粉皮下免疫疗法（SCIT）与舌下免疫治疗（SLIT）和对症治疗的成本效益比较分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba4212534824)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738510, encodeId=c9341e38510a0, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=新期刊质量的CiteScore指数挑战影响因子，为时尚早, objectType=article, longId=84566, objectId=7906845666e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7906845666e, replyNumber=0, likeNumber=75, createdTime=2017-08-29, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7906845666e, moduleTitle=新期刊质量的CiteScore指数挑战影响因子，为时尚早, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7906845666e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738508, encodeId=eba61e385088c, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=按照新的期刊评价指数CiteScore，柳叶刀竟然没进前200名, objectType=article, longId=84542, objectId=6f0e845427f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f0e845427f, replyNumber=0, likeNumber=125, createdTime=2017-03-22, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f0e845427f, moduleTitle=按照新的期刊评价指数CiteScore，柳叶刀竟然没进前200名, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f0e845427f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738516, encodeId=e3df1e38516c0, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=2017 CITSAC上，五院士发声——引领学术前沿，大家风范势不可挡, objectType=article, longId=104367, objectId=f09d10436e08, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f09d10436e08, replyNumber=0, likeNumber=68, createdTime=2017-07-21, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f09d10436e08, moduleTitle=2017 CITSAC上，五院士发声——引领学术前沿，大家风范势不可挡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f09d10436e08)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738507, encodeId=4d3f1e385077a, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=CiteScore会成为Scopus的杀手锏吗？期刊排名江山待定, objectType=article, longId=84540, objectId=7fdd8454035, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fdd8454035, replyNumber=0, likeNumber=73, createdTime=2017-07-14, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fdd8454035, moduleTitle=CiteScore会成为Scopus的杀手锏吗？期刊排名江山待定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fdd8454035)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738513, encodeId=621e1e3851372, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=CIT2017：钱菊英—理想的LDL-C靶目标——降至新生儿水平, objectType=article, longId=95937, objectId=e5c39593eb3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5c39593eb3, replyNumber=0, likeNumber=93, createdTime=2018-01-10, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5c39593eb3, moduleTitle=CIT2017：钱菊英—理想的LDL-C靶目标——降至新生儿水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5c39593eb3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738511, encodeId=9a141e3851170, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=大会主席谈CIT 2017：CIT走过15载，参会代表从800人增至8000人，顺应学科发展是趋势, objectType=article, longId=94059, objectId=995094059de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=995094059de, replyNumber=0, likeNumber=72, createdTime=2017-11-06, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=995094059de, moduleTitle=大会主席谈CIT 2017：CIT走过15载，参会代表从800人增至8000人，顺应学科发展是趋势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=995094059de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738505, encodeId=0a131e385054c, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=Ann Rheum Dis：Baricitinib可有效治疗类风湿性关节炎（RA-BUILD）, objectType=article, longId=79439, objectId=c312e943903, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c312e943903, replyNumber=0, likeNumber=70, createdTime=2017-08-03, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c312e943903, moduleTitle=Ann Rheum Dis：Baricitinib可有效治疗类风湿性关节炎（RA-BUILD）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c312e943903)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738512, encodeId=c5391e3851232, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=高润霖谈CIT 2017：CIT15载，参会代表从800人增至8000人，为何？, objectType=article, longId=94548, objectId=7aa79454898, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7aa79454898, replyNumber=0, likeNumber=57, createdTime=2017-08-18, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7aa79454898, moduleTitle=高润霖谈CIT 2017：CIT15载，参会代表从800人增至8000人，为何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7aa79454898)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738506, encodeId=0cad1e38506c1, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=影响因子的重量级对手来了--CiteScore问世, objectType=article, longId=84517, objectId=33a88451e23, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33a88451e23, replyNumber=0, likeNumber=76, createdTime=2017-01-27, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33a88451e23, moduleTitle=影响因子的重量级对手来了--CiteScore问世, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33a88451e23)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738509, encodeId=43b41e3850983, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=难道因CiteScore，路透社赶紧把SCI和JCR卖了？, objectType=article, longId=84553, objectId=027b8455395, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=027b8455395, replyNumber=0, likeNumber=72, createdTime=2017-09-23, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=027b8455395, moduleTitle=难道因CiteScore，路透社赶紧把SCI和JCR卖了？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=027b8455395)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738503, encodeId=c6b21e385032f, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=CIT 2016：5大原创临床试验揭晓，标志中国心血管进入原创时代, objectType=article, longId=65944, objectId=bf2a65944c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf2a65944c7, replyNumber=0, likeNumber=54, createdTime=2016-08-21, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf2a65944c7, moduleTitle=CIT 2016：5大原创临床试验揭晓，标志中国心血管进入原创时代, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf2a65944c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738504, encodeId=f4f91e3850478, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=ADA 2016：礼来每周一次降糖药Trulicity（度拉鲁肽）联合甘精胰岛素显著改善2型糖尿病患者血糖控制, objectType=article, longId=71031, objectId=ed04e103173, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed04e103173, replyNumber=0, likeNumber=78, createdTime=2016-09-07, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed04e103173, moduleTitle=ADA 2016：礼来每周一次降糖药Trulicity（度拉鲁肽）联合甘精胰岛素显著改善2型糖尿病患者血糖控制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed04e103173)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738499, encodeId=71341e38499a9, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=CIT-2005肾动脉介入演示病例, objectType=article, longId=59928, objectId=3976599287a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3976599287a, replyNumber=0, likeNumber=49, createdTime=2016-02-25, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3976599287a, moduleTitle=CIT-2005肾动脉介入演示病例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3976599287a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738502, encodeId=0ca41e385029a, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=NEJM：新药物Baricitinib治疗难治性类风湿性关节炎大获成功, objectType=article, longId=65897, objectId=f9b66589efb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9b66589efb, replyNumber=0, likeNumber=98, createdTime=2017-01-16, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9b66589efb, moduleTitle=NEJM：新药物Baricitinib治疗难治性类风湿性关节炎大获成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9b66589efb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738498, encodeId=bb051e38498d9, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=TCT@CIT联合论坛：重要、极难、最热的话题, objectType=article, longId=57698, objectId=40ae5e69815, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40ae5e69815, replyNumber=0, likeNumber=75, createdTime=2016-05-23, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40ae5e69815, moduleTitle=TCT@CIT联合论坛：重要、极难、最热的话题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40ae5e69815)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738501, encodeId=58541e385015f, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=Resuscitation：轻度高碳酸血症影响心脏骤停早期幸存者机械通气脑氧合, objectType=article, longId=63626, objectId=676c636260c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=676c636260c, replyNumber=0, likeNumber=106, createdTime=2016-08-08, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=676c636260c, moduleTitle=Resuscitation：轻度高碳酸血症影响心脏骤停早期幸存者机械通气脑氧合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=676c636260c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738497, encodeId=c2271e3849764, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=Resuscitation：医疗剧乱弹琴，需医务工作者正确引导, objectType=article, longId=55632, objectId=e0a055632b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0a055632b0, replyNumber=0, likeNumber=91, createdTime=2015-09-12, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0a055632b0, moduleTitle=Resuscitation：医疗剧乱弹琴，需医务工作者正确引导, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0a055632b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738496, encodeId=a9361e3849628, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, objectTitle=JAMA Dermatol：托法替尼（Tofacitinib）——白癜风治疗的新希望, objectType=article, longId=53256, objectId=8a4653256e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a4653256e4, replyNumber=0, likeNumber=68, createdTime=2015-07-13, rootId=0, userName=12498877m109暂无昵称, userId=eabf34462441, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a4653256e4, moduleTitle=JAMA Dermatol：托法替尼（Tofacitinib）——白癜风治疗的新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a4653256e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CIT

2020-05-29

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

J Rheumatol ：Baricitinib在类风湿关节炎128周开放标签研究中的安全性和疗效

2017-11-25

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

J Med Econ：草花粉皮下免疫疗法（SCIT）与舌下免疫治疗（SLIT）和对症治疗的成本效益比较分析

2018-10-01

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

新期刊质量的CiteScore指数挑战影响因子，为时尚早

2017-08-29

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

按照新的期刊评价指数CiteScore，柳叶刀竟然没进前200名

2017-03-22

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

2017 CITSAC上，五院士发声——引领学术前沿，大家风范势不可挡

2017-07-21

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

CiteScore会成为Scopus的杀手锏吗？期刊排名江山待定

2017-07-14

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

CIT2017：钱菊英—理想的LDL-C靶目标——降至新生儿水平

2018-01-10

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

大会主席谈CIT 2017：CIT走过15载，参会代表从800人增至8000人，顺应学科发展是趋势

2017-11-06

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

Ann Rheum Dis：Baricitinib可有效治疗类风湿性关节炎（RA-BUILD）

2017-08-03

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

高润霖谈CIT 2017：CIT15载，参会代表从800人增至8000人，为何？

2017-08-18

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

影响因子的重量级对手来了--CiteScore问世

2017-01-27

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

难道因CiteScore，路透社赶紧把SCI和JCR卖了？

2017-09-23

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

CIT 2016：5大原创临床试验揭晓，标志中国心血管进入原创时代

2016-08-21

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

ADA 2016：礼来每周一次降糖药Trulicity（度拉鲁肽）联合甘精胰岛素显著改善2型糖尿病患者血糖控制

2016-09-07

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

CIT-2005肾动脉介入演示病例

2016-02-25

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

NEJM：新药物Baricitinib治疗难治性类风湿性关节炎大获成功

2017-01-16

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

TCT@CIT联合论坛：重要、极难、最热的话题

2016-05-23

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

Resuscitation：轻度高碳酸血症影响心脏骤停早期幸存者机械通气脑氧合

2016-08-08

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

Resuscitation：医疗剧乱弹琴，需医务工作者正确引导

2015-09-12

12498877m109暂无昵称 (审核中...)

前往app查看评论内容

#CIT#

JAMA Dermatol：托法替尼（Tofacitinib）——白癜风治疗的新希望

2015-07-13

科室
- - 订阅+
  - 更多科室
工具
服务